What is the appropriate management of Celphos (aluminum phosphide) poisoning?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Aluminum Phosphide (Celphos) Poisoning

Aluminum phosphide poisoning requires immediate aggressive supportive care with no specific antidote available; survival depends on early gastric decontamination, aggressive correction of metabolic acidosis, hemodynamic support, and intensive monitoring.

Immediate Priorities

The cornerstone of management is rapid supportive care initiated before the patient deteriorates into refractory shock and cardiac arrest 1, 2, 3. Time is critical—mortality rates of 70-100% are reported even with small ingestions (150-500 mg), making every minute count 3.

Gastric Decontamination (First-Line Intervention)

  • Perform gastric lavage immediately with one of the following:
    • Coconut oil (preferred based on recent successful cases) 2, 4
    • Vegetable oil 1
    • Diluted potassium permanganate 4
  • Administer activated charcoal to reduce phosphine bioavailability 1
  • The goal is to prevent further phosphine gas liberation in the gastrointestinal tract

Metabolic Stabilization

Aggressive correction of metabolic acidosis is essential as it directly correlates with survival:

  • Sodium bicarbonate administration (intravenous) 1, 4
  • Monitor arterial blood gases frequently
  • Consider peritoneal dialysis or hemodialysis for severe refractory metabolic acidosis and acute kidney injury 5
    • Renal replacement therapy improves survival by correcting acidosis when conventional measures fail

Cardiovascular Support

Aluminum phosphide causes refractory shock, cardiac arrhythmias, and cardiogenic shock through mitochondrial dysfunction 3, 6:

  • Intensive hemodynamic monitoring in ICU setting 4
  • Vasopressor support as needed 4
  • Magnesium sulfate (intravenous) acts as a membrane stabilizer and may prevent fatal arrhythmias 3, 4
  • For refractory cardiogenic shock unresponsive to standard measures, consider:
    • Intra-aortic balloon pump 3
    • VA-ECMO (extracorporeal membrane oxygenation) 3—though not specifically studied for aluminum phosphide, the 2023 AHA guidelines support VA-ECMO for refractory cardiogenic shock from poisoning 7

Adjunctive Cardioprotective Therapies

While no specific antidote exists, emerging evidence supports membrane stabilizers and cardioprotective agents 3, 6:

  • Trimetazidine (cardioprotective)
  • N-acetylcysteine (antioxidant)
  • Thiamine, Vitamin C (antioxidants)
  • Hydrocortisone
  • Mannitol 1

These agents target oxidative stress and mitochondrial dysfunction caused by phosphine gas.

Respiratory Management

  • Early endotracheal intubation and mechanical ventilation for respiratory distress 8
  • High-flow oxygen therapy 8
  • Monitor for aspiration pneumonia, which can complicate the clinical course 2

Critical Monitoring Parameters

Monitor continuously for:

  • Cardiac arrhythmias (especially ventricular tachycardia) 3
  • Acute kidney injury (oliguric/anuric renal failure occurs in almost all severe cases) 5
  • Hepatobiliary impairment 3
  • Severe metabolic acidosis with elevated lactate 8
  • Respiratory alkalosis (in inhalational exposure) 8

Common Pitfalls to Avoid

  1. Delayed presentation is deadly—even with delayed arrival, aggressive supportive care can still save lives 2, 3
  2. Don't wait for laboratory confirmation—treat based on history and clinical presentation
  3. Don't underestimate small ingestions—even 150 mg can be fatal 3
  4. Inhalational exposure is underrecognized but equally dangerous, causing neurological deficits including motor neuropathy 8
  5. Avoid complacency after initial stabilization—complications can develop over 24-48 hours

Key Algorithmic Approach

  1. Immediate gastric decontamination (coconut oil lavage + activated charcoal)
  2. Correct metabolic acidosis aggressively (bicarbonate ± dialysis)
  3. Stabilize cardiovascular system (magnesium sulfate + vasopressors + consider ECMO if refractory)
  4. Add cardioprotective agents (trimetazidine, NAC, vitamins)
  5. Intensive monitoring for 48-72 hours minimum

Contact your regional poison center immediately (1-800-222-1222 in US) for real-time expert guidance, as recommended by the 2023 AHA guidelines for all critical poisonings 7.

The evidence consistently shows that survival is possible even in severe cases when aggressive, early, multifaceted supportive care is initiated promptly 1, 2, 3, 4. The absence of a specific antidote makes the quality and timeliness of supportive interventions the primary determinants of mortality and morbidity.

Related Questions

What is the appropriate management of a positive troponin I in a patient with aluminum phosphide (celphos) poisoning?
What intravenous magnesium sulfate dose and infusion schedule should be used in an adult with aluminum‑phosphide (Celphos) poisoning who develops cardiac instability or refractory hypotension, and what are the pediatric dosing recommendations?
Should anticoagulant therapy be given to a patient with aluminium phosphide (Celphos) poisoning who has an elevated troponin level?
What are the complications of Celphos (zinc phosphide and aluminum phosphide) poisoning?
Can metabolic acidosis cause hypotension?
In a 35-year-old healthy non-smoker with mild COVID-19, normal oxygenation and two small infiltrates on chest X-ray, should antiviral therapy be given?
Is it advisable to start guanfacine (guanfacine) on a patient who reports having ADHD and has previously taken Adderall (mixed amphetamine salts) without documented confirmation of the diagnosis?
In a patient with abnormal urinalysis (leukocyte esterase 3+, nitrite positive, white blood cells >25 per high-power field, bacteria) who is currently receiving levofloxacin 750 mg orally daily for pneumonia, should I continue levofloxacin alone and defer adding any additional antimicrobial until urine culture and susceptibility results are available?
In a 40‑year‑old man with androgenetic alopecia, how does the efficacy of oral finasteride taken three times weekly compare with topical finasteride applied three times weekly for hair loss treatment?
Which joints are most commonly affected by hyperuricemia?
What is the appropriate evaluation and management for a 26‑year‑old adult presenting with recurrent, week‑long skin lesions over the past two months and new arthralgia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.